Norlevorphanol
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Monkbot (talk | contribs) at 20:51, 1 January 2021 (Task 18 (cosmetic): eval 1 template: del empty params (4×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:51, 1 January 2021 by Monkbot (talk | contribs) (Task 18 (cosmetic): eval 1 template: del empty params (4×);)
Pharmaceutical compound
 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | ? |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.014.761  |
| Chemical and physical data | |
| Formula | C16H21NO |
| Molar mass | 243.350 g·mol−1 |
Norlevorphanol is an opioid analgesic of the morphinan family that was never marketed.[1] It is the levo-isomer of 3-hydroxymorphinan (morphinan-3-ol). Norlevorphanol is a Schedule I Narcotic controlled substance in the United States with an ACSCN of 9634 and in 2014 it had an annual aggregate manufacturing quota of 52 grams. It is used as the hydrobromide (free base conversion ratio 0.750) and hydrochloride (0.870).[2]
See also
References
- ^ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- ^ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html
Hidden categories: